Updates

November 30, 2020November 30, 2020
Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

Applications for a next round of Sjögren’s Foundation research grants are being accepted from U.S. investigators working to better understand Sjögren’s syndrome, a chronic immune ... Read more
November 26, 2020November 25, 2020
New $100M Program Aims to Improve Diversity in Clinical Trials

A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and ... Read more
November 23, 2020November 23, 2020
Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

Primary Sjögren’s syndrome (pSS) syndrome can be classified based on the extent of organ involvement, fatigue, and pain, with symptoms varying substantially from patient ... Read more
November 16, 2020November 16, 2020
LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Wize Pharma‘s LO2A eye drops result in clinically meaningful improvements in dry eye signs and symptoms in people with Sjögren’s syndrome, topline results from an ... Read more
November 9, 2020November 9, 2020
Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Long-term use of hydroxychloroquine significantly lowers the risk of coronary artery disease, the most common form of heart disease, in people with Sjögren’s syndrome, a ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 22, 2018

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

News

Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of ... Read more

Updates

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

New $100M Program Aims to Improve Diversity in Clinical Trials

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Subscribe to our mailing list

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome

Bcl-6 ‘Master Regulator’ Discovery Sheds Light on Autoimmune Diseases Such as Sjogren’s

B-cell Protein May Contribute to Development of Primary Sjogren’s Syndrome, Study Suggests

Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year

Researchers Shed Light on Genetics Behind Sex-based Vulnerability to Sjögren’s, Other Diseases

Research Implicates MicroRNA in Primary Sjögren’s Syndrome Eye Inflammation

Damage to Eye Surface Evident in Sjögren Patients, Study Reports

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Bacteria in Mouth May Trigger Inflammation Damaging to Salivary Glands

Vaginal Dryness in Sjögren’s Traced Partly to Blood Vessel Defects

Sjögren’s Symptoms Not Affected by Seasonal Changes, Study Finds

Poor Sleep Linked to Fatigue and Disease Activity in Primary Sjögren’s

Symptoms Outside Glands in Sjögren’s Patients May Increase Risk of Other Diseases

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome